Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice

Cell

Volumn 147, Issue 2, 2011, Pages 293-305

  Seimetz, Michael ^a   Parajuli, Nirmal ^a   Pichl, Alexandra ^a   Veit, Florian ^a   Kwapiszewska, Grazyna ^a   Weisel, Friederike C ^a   Milger, Katrin ^a   Egemnazarov, Bakytbek ^a   Turowska, Agnieszka ^d   Fuchs, Beate ^a   Nikam, Sandeep ^b   Roth, Markus ^a   Sydykov, Akylbek ^a   Medebach, Thomas ^a   Klepetko, Walter ^c   Jaksch, Peter ^c   Dumitrascu, Rio ^a   Garn, Holger ^d   Voswinckel, Robert ^b   Kostin, Sawa ^b   Seeger, Werner ^a   Schermuly, Ralph T ^b   Grimminger, Friedrich ^a   Ghofrani, Hossein A ^a   Weissmann, Norbert ^a   more..

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Biomedical Research Center (BMFZ)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CYCLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N6 (1 IMINOETHYL)LYSINE; PEROXYNITRITE; TOBACCO SMOKE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CHIMERA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GRANULOCYTE; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SMOKING; WILD TYPE;

MUS; NICOTIANA TABACUM;

EID: 80054696408     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2011.08.035     Document Type: Article

References (61)

1. A.G. Agustí, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J. 21 2003 347 360 (Pubitemid 36204553)
2. K. Asosingh, M.A. Aldred, A. Vasanji, J. Drazba, J. Sharp, C. Farver, S.A. Comhair, W. Xu, L. Licina, and L. Huang Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension Am. J. Pathol. 172 2008 615 627 (Pubitemid 351354535)
3. E.D. Austin, M.T. Rock, C.A. Mosse, C.L. Vnencak-Jones, S.M. Yoder, I.M. Robbins, J.E. Loyd, and B.O. Meyrick T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension Respir. Med. 104 2010 454 462
4. D.A. Bigatel, J.R. Elmore, D.J. Carey, G. Cizmeci-Smith, D.P. Franklin, and J.R. Youkey The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms J. Vasc. Surg. 29 1999 130 138 discussion 138-139
5. P.N. Black, P.S. Ching, B. Beaumont, S. Ranasinghe, G. Taylor, and M.J. Merrilees Changes in elastic fibres in the small airways and alveoli in COPD Eur. Respir. J. 31 2008 998 1004
6. C. Bogdan Nitric oxide and the immune response Nat. Immunol. 2 2001 907 916 (Pubitemid 32976162)
7. C. Brindicci, K. Ito, O. Torre, P.J. Barnes, and S.A. Kharitonov Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients Chest 135 2009 353 367
8. K.F. Chung, and I.M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J. 31 2008 1334 1356
9. A. Churg, M. Cosio, and J.L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am. J. Physiol. Lung Cell. Mol. Physiol. 294 2008 L612 L631
10. M. Corti, A.R. Brody, and J.H. Harrison Isolation and primary culture of murine alveolar type II cells Am. J. Respir. Cell Mol. Biol. 14 1996 309 315 (Pubitemid 126440495)
11. M.J. Cuttica, T. Langenickel, A. Noguchi, R.F. Machado, M.T. Gladwin, and M. Boehm Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage Am. J. Respir. Cell Mol. Biol. 45 2011 62 71
12. L.W. Ellisen Smoking and emphysema: the stress connection Nat. Med. 16 2010 754 755
13. C.A. Feghali-Bostwick, A.S. Gadgil, L.E. Otterbein, J.M. Pilewski, M.W. Stoner, E. Csizmadia, Y. Zhang, F.C. Sciurba, and S.R. Duncan Autoantibodies in patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 177 2008 156 163
14. E. Ferrer, V.I. Peinado, M. Díez, J.L. Carrasco, M.M. Musri, A. Martínez, R. Rodríguez-Roisin, and J.A. Barber Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig Respir. Res. 10 2009 76
15. A. Huertas, and P. Palange Circulating endothelial progenitor cells and chronic pulmonary diseases Eur. Respir. J. 37 2011 426 431
16. D.M. Lawrence, R.S. Singh, D.P. Franklin, D.J. Carey, and J.R. Elmore Rapamycin suppresses experimental aortic aneurysm growth J. Vasc. Surg. 40 2004 334 338 (Pubitemid 39055899)
17. K.J. Leco, P. Waterhouse, O.H. Sanchez, K.L. Gowing, A.R. Poole, A. Wakeham, T.W. Mak, and R. Khokha Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3) J. Clin. Invest. 108 2001 817 829 (Pubitemid 32884192)
18. O.A. Minai, A. Chaouat, and S. Adnot Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective Chest 137 6, Suppl 2010 39S 51S
19. M. Mittal, M. Roth, P. König, S. Hofmann, E. Dony, P. Goyal, A.C. Selbitz, R.T. Schermuly, H.A. Ghofrani, and G. Kwapiszewska Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature Circ. Res. 101 2007 258 267 (Pubitemid 47344075)
20. S. Moncada, and J.D. Erusalimsky Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3 2002 214 220
21. W.M. Moore, R.K. Webber, G.M. Jerome, F.S. Tjoeng, T.P. Misko, and M.G. Currie L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase J. Med. Chem. 37 1994 3886 3888 (Pubitemid 24379677)
22. G.T. Motz, B.L. Eppert, S.C. Wesselkamper, J.L. Flury, and M.T. Borchers Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice Am. J. Respir. Crit. Care Med. 181 2010 1223 1233
23. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498 1504 (Pubitemid 27216360)
24. W. Niedbala, B. Cai, H. Liu, N. Pitman, L. Chang, and F.Y. Liew Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40 Proc. Natl. Acad. Sci. USA 104 2007 15478 15483
25. M. Ochs, J.R. Nyengaard, A. Jung, L. Knudsen, M. Voigt, T. Wahlers, J. Richter, and H.J. Gundersen The number of alveoli in the human lung Am. J. Respir. Crit. Care Med. 169 2004 120 124 (Pubitemid 38233898)
26. V.I. Peinado, S. Pizarro, and J.A. Barber Pulmonary vascular involvement in COPD Chest 134 2008 808 814
27. P. Ponnuswamy, E. Ostermeier, A. Schröttle, J. Chen, P.L. Huang, G. Ertl, B. Nieswandt, and P.J. Kuhlencordt Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase Am. J. Pathol. 174 2009 2400 2410
28. D.A. Potoka, J.S. Upperman, X.R. Zhang, J.R. Kaplan, S.J. Corey, A. Grishin, R. Zamora, and H.R. Ford Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G861 G869
29. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, J. Zielinski Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 176 2007 532 555 (Pubitemid 47403272)
30. F.L. Ricciardolo, P.J. Sterk, B. Gaston, and G. Folkerts Nitric oxide in health and disease of the respiratory system Physiol. Rev. 84 2004 731 765 (Pubitemid 38823765)
31. R.T. Schermuly, E. Dony, H.A. Ghofrani, S. Pullamsetti, R. Savai, M. Roth, A. Sydykov, Y.J. Lai, N. Weissmann, W. Seeger, and F. Grimminger Reversal of experimental pulmonary hypertension by PDGF inhibition J. Clin. Invest. 115 2005 2811 2821 (Pubitemid 41434408)
32. D. Singh, D. Richards, R.G. Knowles, S. Schwartz, A. Woodcock, S. Langley, and B.J. O'Connor Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma Am. J. Respir. Crit. Care Med. 176 2007 988 993 (Pubitemid 350127842)
33. S. Stenger, H. Thuring, M. Rollinghoff, P. Manning, and C. Bogdan L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo Eur. J. Pharmacol. 294 1995 703 712 (Pubitemid 26016773)
34. R.A. Stockley, D. Mannino, and P.J. Barnes Burden and pathogenesis of chronic obstructive pulmonary disease Proc. Am. Thorac. Soc. 6 2009 524 526
35. C. Szabó, H. Ischiropoulos, and R. Radi Peroxynitrite: biochemistry, pathophysiology and development of therapeutics Nat. Rev. Drug Discov. 6 2007 662 680 (Pubitemid 47207751)
36. L. Taraseviciene-Stewart, and N.F. Voelkel Molecular pathogenesis of emphysema J. Clin. Invest. 118 2008 394 402 (Pubitemid 351206526)
37. M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N.M. Siafakas Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD Chest 127 2005 1911 1918
38. N.F. Voelkel, R.W. Vandivier, and R.M. Tuder Vascular endothelial growth factor in the lung Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 L209 L221
39. R. Voswinckel, T. Ziegelhoeffer, M. Heil, S. Kostin, G. Breier, T. Mehling, R. Haberberger, M. Clauss, A. Gaumann, W. Schaper, and W. Seeger Circulating vascular progenitor cells do not contribute to compensatory lung growth Circ. Res. 93 2003 372 379 (Pubitemid 37048250)
40. N. Weissmann, A. Dietrich, B. Fuchs, H. Kalwa, M. Ay, R. Dumitrascu, A. Olschewski, U. Storch, M. Mederos y Schnitzler, and H.A. Ghofrani Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange Proc. Natl. Acad. Sci. USA 103 2006 19093 19098 (Pubitemid 350002833)
41. D.A. Wink, and J.B. Mitchell Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic. Biol. Med. 25 1998 434 456 (Pubitemid 28390299)
42. J.L. Wright, and A. Churg Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig Am. Rev. Respir. Dis. 142 1990 1422 1428
43. J.L. Wright, and A. Churg Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig Exp. Lung Res. 17 1991 997 1009
44. J.L. Wright, H. Tai, and A. Churg Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig J. Appl. Physiol. 100 2006 672 678 (Pubitemid 43671624)
45. J.L. Wright, S. Zhou, O. Preobrazhenska, C. Marshall, D.D. Sin, I. Laher, S. Golbidi, and A.M. Churg Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling Am. J. Respir. Crit. Care Med. 183 2011 50 58
46. T. Yoshida, and R.M. Tuder Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease Physiol. Rev. 87 2007 1047 1082 (Pubitemid 47084676)
47. T. Yoshida, I. Mett, A.K. Bhunia, J. Bowman, M. Perez, L. Zhang, A. Gandjeva, L. Zhen, U. Chukwueke, and T. Mao Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema Nat. Med. 16 2010 767 773
48. B.S. Zuckerbraun, B.Y. Chin, B. Wegiel, T.R. Billiar, E. Czsimadia, J. Rao, L. Shimoda, E. Ifedigbo, S. Kanno, and L.E. Otterbein Carbon monoxide reverses established pulmonary hypertension J. Exp. Med. 203 2006 2109 2119 (Pubitemid 44352232)
49. Dumitrascu, R.; Weissmann, N.; Ghofrani, H.A.; Dony, E.; Beuerlein, K.; Schmidt, H.; Stasch, J.P.; Gnoth, M.J.; Seeger, W.; Grimminger, F.; and Schermuly, R.T. (2006). Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 113, 286-295.
50. Fink, L.; Kohlhoff, S.; Stein, M.M.; Hänze, J.; Weissmann, N.; Rose, F.; Akkayagil, E.; Manz, D.; Grimminger, F.; Seeger, W.; and Bohle, R.M. (2002). cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am. J. Pathol. 160, 81-90. (Pubitemid 34052269)
51. Garn, H.; Siese, A.; Stumpf, S.; Wensing, A.; Renz, H.; and Gemsa, D. (2006). Phenotypical and functional characterization of alveolar macrophage subpopulations in the lungs of NO2-exposed rats. Respir. Res. 7, 4.
52. Held, H.D.; and Uhlig, S. (2000). Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am. J. Respir. Crit. Care Med. 162, 1547-1552.
53. Kuzkaya, N.; Weissmann, N.; Harrison, D.G.; and Dikalov, S. (2003). Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 278, 22546-22554. (Pubitemid 36830310)
54. MacArthur, P.H.; Shiva, S.; and Gladwin, M.T. (2007). Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 93-105. (Pubitemid 46720142)
55. Marshall, C.; Mamary, A.J.; Verhoeven, A.J.; and Marshall, B.E. (1996). Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 15, 633-644. (Pubitemid 126440603)
56. McGrath-Morrow, S.A.; Cho, C.; Soutiere, S.; Mitzner, W.; and Tuder, R. (2004). The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1- deficient mice. Am. J. Respir. Cell Mol. Biol. 30, 635-640. (Pubitemid 38591214)
57. Mittal, M.; Roth, M.; König, P.; Hofmann, S.; Dony, E.; Goyal, P.; Selbitz, A.C.; Schermuly, R.T.; Ghofrani, H.A.; Kwapiszewska, G.; et al. (2007). Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 101, 258-267. (Pubitemid 47344075)
58. Ochs, M.; Nyengaard, J.R.; Jung, A.; Knudsen, L.; Voigt, M.; Wahlers, T.; Richter, J.; and Gundersen, H.J. (2004). The number of alveoli in the human lung. Am. J. Respir. Crit. Care Med. 169, 120-124. (Pubitemid 38233898)
59. Rabinovitch, M.; Gamble, W.J.; Miettinen, O.S.; and Reid, L. (1981). Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am. J. Physiol. 240, H62-H72.
60. Voswinckel, R.; Ziegelhoeffer, T.; Heil, M.; Kostin, S.; Breier, G.; Mehling, T.; Haberberger, R.; Clauss, M.; Gaumann, A.; Schaper, W.; and Seeger, W. (2003). Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ. Res. 93, 372-379. (Pubitemid 37048250)
61. Woyda, K.; Koebrich, S.; Reiss, I.; Rudloff, S.; Pullamsetti, S.S.; Rühlmann, A.; Weissmann, N.; Ghofrani, H.A.; Günther, A.; Seeger, W.; et al. (2009). Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia. Eur. Respir. J. 33, 861-870.